Related Experiment Video
Updated: Jul 19, 2026

12:51
Murine Model of Hindlimb Ischemia
Published on: January 21, 2009
p66ShcA modulates tissue response to hindlimb ischemia
Germana Zaccagnini1, Fabio Martelli, Pasquale Fasanaro
1Laboratorio di Patologia Vascolare, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy.
Circulation
|June 3, 2004
Summary
Mice lacking p66ShcA protein showed reduced tissue damage and cell death following ischemia and reperfusion. This suggests p66ShcA is key in these injury pathways, offering a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cellular Biology
- Physiology
Background:
- Oxidative stress is central to ischemia and ischemia/reperfusion (I/R) injury.
- p66ShcA-null mice exhibit reduced reactive oxygen species and enhanced resistance to oxidative stress-induced cell death.
Purpose of the Study:
- To investigate the role of p66ShcA in tissue damage following acute ischemia and I/R.
- To determine if p66ShcA deficiency alters susceptibility to ischemic injury.
Main Methods:
- Induction of unilateral hindlimb ischemia and I/R in p66ShcA wild-type and p66ShcA-null mice.
- Assessment of blood perfusion, tissue damage (capillary density, muscle fiber necrosis), and apoptosis levels.
- In vitro analysis of isolated cells under simulated ischemic conditions.
Main Results:
- p66ShcA-null mice showed significantly less capillary density decrease and muscle fiber necrosis compared to wild-type.
- Lower levels of apoptotic endothelial cells and myofibers were observed in p66ShcA-null mice post-ischemia.
- Cells from p66ShcA-null mice demonstrated resistance to apoptosis and reduced oxidative stress in vitro.
Conclusions:
- p66ShcA is critical in the cell death pathways activated by acute ischemia and I/R.
- Targeting p66ShcA presents a potential therapeutic strategy for mitigating ischemic tissue damage.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

